利用基因组学区分多原发肺癌与肺内转移
该研究对37例多发性肺癌患者的76个肿瘤样本行配对末端测序,评估染色体易位断裂点不一致映射在判定转移性疾病中的效用。配对末端测序可对所有肿瘤对进行谱系分类,而组织学复核在33对同组织学肿瘤对中误判9对(27%)。染色体易位高度独特且普遍,可作为多灶性肺癌谱系判定的确定性技术。
要点
- 配对末端测序可对所有肿瘤对进行谱系分类,组织学复核在同组织学肿瘤对中误判率为27%(9/33)。
- 7例因病理医师意见不一致,组织病理学谱系被判为不确定。
- 2例病理医师一致判定为转移的病例未发现共享断裂点,提示为独立原发。
核心结论
- 肺癌中染色体易位高度独特且普遍,为多灶性肺癌的谱系判定提供了有用且确定的技术。
研究设计与样本
- 对37例多发性肺癌患者的76个不同肿瘤提取DNA行配对末端测序,评估不一致映射断裂点和染色体拷贝数水平。
- 22例有血液来源DNA可用于胚系评估。
- 对17例患者的肿瘤对额外行肺癌二代测序面板检测。
主要发现
- 配对末端测序能够对所有肿瘤对进行谱系分类。
- 组织学复核在33对同组织学肿瘤对比较中,有9对(27%)谱系分类错误。
- 基于复核病理医师之间的分歧,7例的组织病理学谱系被分类为不确定。
- 在2例病理医师一致判定为转移的病例中,未发现共享断裂点,提示为独立原发。
- 通过肺癌二代测序面板评估共享染色体拷贝数改变和驱动突变虽有信息价值,但在所有病例中均不能确定性判定谱系。
关键数值与推荐
- 组织学复核在同组织学肿瘤对中误判9/33(27%)。
- 通过算法过滤的胚系断裂点常见,但平均少于3个,且均具有小灶性重排或转座子的可预测结构。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Genomic technologies present a promising mechanism of resolving the clinical dilemma of distinguishing independent primary tumors from intrapulmonary metastases in NSCLC. We evaluated the utility of discordant mapping somatic junctions from chromosomal rearrangements in diagnosing metastatic disease compared to the current standard histologic review. MATERIAL AND METHODS: Mate-pair sequencing was performed on DNA extracted from 76 distinct tumors from 37 cases of multiple lung cancers. Discordant mapping junctions and chromosomal copy levels were assessed for each tumor. Blood-derived DNA was available on 22 of these cases for germline assessments. A lung cancer next-generation sequencing panel was additionally performed on tumor pairs from 17 patients. RESULTS: Whereas mate-pair sequencing was able to classify lineage in all tumor pairs, histologic review appeared to misclassify lineage in 9 of 33 (27%) same-histology tumor pair comparisons. Based on disagreement between the reviewing pathologists, histopathologic lineage was classified as indeterminate in seven cases. In two cases where pathologists agreed on a metastatic call, no shared junctions were found suggesting independent primaries. Although germline junctions passing algorithmic filters were common, on average less than three were present and all had predictable structures of small focal rearrangements or transposons. Evaluation of shared chromosomal copy changes and driver mutations through a lung cancer next-generation sequencing panel, while informative, were nondefinitive in calling lineage in all cases. CONCLUSIONS: The highly unique nature and prevalence of chromosomal rearrangement in lung cancers provide a useful and definitive technique for calling lineage in multifocal lung cancer.
引用
- Murphy SJ, Harris FR, Kosari F, et al. Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer. J Thorac Oncol. 2019. PMID: 31103780. doi:10.1016/j.jtho.2019.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。